Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702560 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
We found that UTUC with VH harbored aggressive biologic features, and VH was an independent prognostic factor for CSS and OS on both univariate and multivariate analyses. In addition, UTUC with VH group had poorer survival outcomes than pure UTUC group in patients who received adjuvant chemotherapy. Consequently, adjuvant treatment modalities other than adjuvant chemotherapy should be considered in this group.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jung Kwon M.D., Kyung Chul M.D., Ph.D., Chang Wook M.D., Ph.D., Cheol M.D., Ph.D., Hyun Hoe M.D., Ph.D., Ja Hyeon M.D., Ph.D.,